JPRN-UMIN000005446已完成1 期
A phase I/II study of docetaxel, nedaplatin and 5-fluorouracil with concurrent radiotherapy(DNF-R) in patients with esophageal cancer - A phase I/II study of DNF-R in patients with esophageal cancer
Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)0 个研究点目标入组 28 人开始时间: 2011年4月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 78years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) No prior chemotherapy regimen. (2) history of drug hypersensitivity. (3) active concomitant malignancy. (4) serious complications (severe heart disease, active infection) (5) pregnant or lactating females. (6) The investigator considers not suitable for the study.
研究者
相似试验
已完成
不适用
Phase I/II study of docetaxel/nedaplatin/5-FU for advanced esophageal cancerEsophageal cancerJPRN-UMIN000006615Chiba University40
已完成
1 期
Phase 1 study of Docetaxel and Oxaliplatin and TS-1 for unresectable / recurrent gastric cancer (KOGC-06)unresectable / recurrent gastric cancerJPRN-UMIN000015723Keio University School of Medicine, Department of Surgery5
已完成
1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancerGastric cancerJPRN-UMIN000000978Shizuoka Cancer Center18
招募中
2 期
The Phase II Study of Docetaxel plus Nedaplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Canceron-small cell lung cancerJPRN-UMIN000004634Shiga University of Medical Science30
招募中
不适用
A Phase II trial of Nedaplatin, 5FU and Docetaxel for induction chemotherapy with Local advanced squamous cell carcinoma of the Head and Neckocal advanced squamous cell carcinoma of the Head and NeckJPRN-UMIN000022191Kindai nara hospital30